Collegium Pharmaceutical (COLL) Other Non-Current Liabilities (2018 - 2025)

Collegium Pharmaceutical's (COLL) quarterly Other Non-Current Liabilities came in at $19000.0 in Q3 2025, down 99.54% year-on-year from $4.1 million in Q3 2024, and down 50.0% quarter-over-quarter from $38000.0 in Q2 2025.

Collegium Pharmaceutical (COLL) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends

Collegium Pharmaceutical's Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $19000.0 for Q3 2025.

  • On a quarterly basis, Other Non-Current Liabilities fell 99.54% year-over-year to $19000.0 in Q3 2025; TTM through Sep 2025 was $19000.0, a 99.54% decrease from a year earlier, with the FY2024 full-year figure at $1.2 million, changed N/A from the prior year.
  • Other Non-Current Liabilities slipped to $19000.0 in Q3 2025 per COLL's latest filing, from $38000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.1 million in Q3 2024 and bottomed at $19000.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Collegium Pharmaceutical 1.14 Bn 853.50 Mn 117.25 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 19,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 396,000.00
Dec 31, 2024 1.18 Mn
Sep 30, 2024 4.10 Mn
Dec 31, 2018 676,000.00
Sep 30, 2018 284.83 Mn
Jun 30, 2018 314.45 Mn
Mar 31, 2018 343.73 Mn